SCHEMBL29888161

SCHEMBL29888161

Cc1ccc(Oc2ccc([N+](=O)[O-])cc2C)cn1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 6/20 0.53
KMT2A Q03164 6/20 0.53
HTT P42858 4/20 0.47
ALDH1A1 P00352 6/20 0.46
MAPT P10636 6/20 0.46
TDP1 Q9NUW8 2/20 0.46
TSHR P16473 1/20 0.46
HSPB1 P04792 2/20 0.45
CYP3A4 P08684 1/20 0.44
PDE7A Q13946 1/20 0.44
S1PR4 O95977 1/20 0.43
EGFR P00533 1/20 0.43
ERBB2 P04626 1/20 0.43
ERBB3 P21860 1/20 0.43
ERBB4 Q15303 1/20 0.43
GAA P10253 3/20 0.43
LMNA P02545 2/20 0.43
KDM4E B2RXH2 1/20 0.43
GLA P06280 1/20 0.43
THRB P10828 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL216106 1.00 MEN1 (0.53) MEN1KMT2AHTTALDH1A1MAPT
SCHEMBL30929726 0.86 HSPB1 (0.49) MEN1KMT2AHTTALDH1A1MAPT
SCHEMBL1193081 0.86 PDE7A (0.48) MEN1KMT2AHTTALDH1A1MAPT
SCHEMBL1406554 0.86 KMT2A (0.63) MEN1KMT2AHTTALDH1A1MAPT
SCHEMBL1554051 0.86 ALDH1A1 (0.44) MEN1KMT2AHTTALDH1A1MAPT
SCHEMBL24167691 0.86 ALDH1A1 (0.45) MEN1KMT2AHTTALDH1A1MAPT
SCHEMBL1192920 0.86 MEN1 (0.49) MEN1KMT2AHTTALDH1A1MAPT
SCHEMBL1406484 0.86 HSPB1 (0.57) MEN1KMT2AHTTALDH1A1MAPT
SCHEMBL5565238 0.86 HSPB1 (0.49) MEN1KMT2AHTTALDH1A1MAPT
SCHEMBL30879433 0.86 ALDH1A1 (0.45) MEN1KMT2AHTTALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117980309-A Tricyclic fused pyrimidine compounds useful as HER2 inhibitors 百时美施贵宝公司 2024-05-03 CN disclosed
EP-4267137-A1 LACTAM (HETERO)ARYLFUSEDPYRIMIDINE DERIVATIVES AS INHIBITORS OF ERBB2 Enliven Inc. (US) 2023-11-01 EP disclosed
WO-2022140769-A1 LACTAM (HETERO)ARYLFUSEDPYRIMIDINE DERIVATIVES AS INHIBITORS OF ERBB2 ENLIVEN THERAPEUTICS, INC. (US) 2022-06-30 WO disclosed